Bottom Line: Leronlimab is an unapproved drug atte
Post# of 148187
(Total Views: 351)
Posted On: 03/11/2020 1:19:47 PM
Re: craigakess #20997
Bottom Line: Leronlimab is an unapproved drug attempting time treat a new indication.
The process, I imagine, would be quicker with an approved medication. The virus appears to be spreading around the world so I don’t think there’ll be a shortage of potential trial candidates, but we have to get the drug to this patients in a country that a trial is improved in.
The process, I imagine, would be quicker with an approved medication. The virus appears to be spreading around the world so I don’t think there’ll be a shortage of potential trial candidates, but we have to get the drug to this patients in a country that a trial is improved in.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼